SIMVASTATIN (MK 733) IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A 2-YEAR TRIAL

被引：0
|
作者：
LECLERCQ, V
HARVENGT, C
机构：
[1] CATHOLIC UNIV LOUVAIN, PHARMACOTHERAPY LAB, 53 AVE E MOUNIER, B-1200 BRUSSELS, BELGIUM
[2] ST LUC UNIV CLIN, DEPT INTERNAL MED, B-1200 BRUSSELS, BELGIUM
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1989年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：76 / 81
页数：6
相关论文
共 50 条
  • [1] SIMVASTATIN (MK-733) - A POTENT CHOLESTEROL-SYNTHESIS INHIBITOR IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MOL, MJTM
    ERKELENS, DW
    LEUVEN, JAG
    SCHOUTEN, JA
    STALENHOEF, AFH
    ATHEROSCLEROSIS, 1988, 69 (2-3) : 131 - 137
  • [2] SIMVASTATIN (MK 733) - AN EFFECTIVE TREATMENT FOR HYPERCHOLESTEROLEMIA
    LINTOTT, CJ
    SCOTT, RS
    NYE, ER
    ROBERTSON, MC
    SUTHERLAND, WHF
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (04): : 317 - 320
  • [3] A 4-year trial of simvastatin in the treatment of patients with heterozygous familial hypercholesterolemia
    Kitatani, M
    Koizumi, J
    Inazu, A
    Kajinami, K
    Mabuchi, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (01): : 62 - 71
  • [4] EFFICACY OF SIMVASTATIN PLUS CHOLESTYRAMINE IN THE 2-YEAR TREATMENT OF HETEROZYGOUS HYPERCHOLESTEROLEMIA
    DACOL, PG
    CATTIN, L
    VALENTI, M
    FISICARO, M
    FERUGLIO, FS
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (05): : 798 - 808
  • [5] BEZAFIBRATE AND SIMVASTATIN (MK-733) IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA
    SMITH, DHG
    NEUTEL, JM
    JANKELOW, D
    MYBURGH, DP
    SOUTH AFRICAN MEDICAL JOURNAL, 1990, 77 (10): : 500 - 503
  • [6] PLASMAPHERESIS DRUG STUDY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - RESULTS OF 2-YEAR CORONARY ANGIOGRAMS
    STEIN, EA
    KIRKEEIDE, R
    NISHIKAWA, A
    GOULD, KL
    MELLIES, MJ
    RIESENBERG, JS
    LAMKIN, GE
    ARTERIOSCLEROSIS, 1987, 7 (05): : A515 - A515
  • [7] EZETIMIBE COADMINISTERED WITH SIMVASTATIN IN ADOLESCENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Vissers, M. N.
    Rodney, R.
    Trip, M.
    van der Graaf, A.
    Gagne, C.
    Strony, J.
    Yang, B.
    Shi, G.
    Veltri, E.
    Cuffie-Jackson, C. A.
    Kastelein, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 189 - 189
  • [8] Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin
    Bo, M
    Nicolello, MT
    Fiandra, U
    Mercadante, G
    Piliego, T
    Fabris, F
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2001, 11 (01) : 17 - 24
  • [9] EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA-LIPIDS IN FAMILIAL HYPERCHOLESTEROLEMIA
    MOL, MJTM
    LEUVEN, JAG
    ERKELENS, DW
    SCHOUTEN, JA
    STALENHOEF, AFH
    LANCET, 1986, 2 (8513): : 936 - 939
  • [10] MK-733 - POTENT INHIBITOR OF CHOLESTEROL-SYNTHESIS IN FAMILIAL HYPERCHOLESTEROLEMIA
    STALENHOEF, AF
    LEUVEN, JAG
    SCHOUTEN, JA
    ERKELENS, DW
    ARTERIOSCLEROSIS, 1987, 7 (05): : A516 - A516
12345